Comparative evaluation of curcumin and resveratrol in breast cancer: network pharmacology, molecular docking, and in-vitro radio-modulating validation in MDA-MB-231 cells.
- DOI
- 10.1007/s40203-026-00677-6
- Published
- 2026
- Container
- In silico pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40203-026-00677-6,
title = {Comparative evaluation of curcumin and resveratrol in breast cancer: network pharmacology, molecular docking, and in-vitro radio-modulating validation in MDA-MB-231 cells.},
author = {Sukumaran N and Senbagavadivoo SC and Raman A and Tamizhmani P and Packiaraj G and Velusamy T},
year = {2026},
journal = {In silico pharmacology},
doi = {10.1007/s40203-026-00677-6},
url = {https://doi.org/10.1007/s40203-026-00677-6}
}RIS
TY - JOUR TI - Comparative evaluation of curcumin and resveratrol in breast cancer: network pharmacology, molecular docking, and in-vitro radio-modulating validation in MDA-MB-231 cells. AU - Sukumaran N AU - Senbagavadivoo SC AU - Raman A AU - Tamizhmani P AU - Packiaraj G AU - Velusamy T PY - 2026 JO - In silico pharmacology DO - 10.1007/s40203-026-00677-6 UR - https://doi.org/10.1007/s40203-026-00677-6 ER -
APA
N, S., SC, S., A, R., P, T., G, P., & T, V. (2026). Comparative evaluation of curcumin and resveratrol in breast cancer: network pharmacology, molecular docking, and in-vitro radio-modulating validation in MDA-MB-231 cells.. In silico pharmacology. https://doi.org/10.1007/s40203-026-00677-6
Source records
- pubmed · retrieved 2026-09-27T16:53:38.061Z
- europe-pmc · retrieved 2026-09-27T16:53:38.085Z